NCT06667063View on ClinicalTrials.gov

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

RecruitingOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
COVID-19Influenza
Interventions
OTHER

Nasal swab/Nasopharyngeal swab/Blood sample collection

Collect nasal or nasopharyngeal swab samples, 15ml anticoagulant samples and 3ml procoagulant samples, as well as 2ml blood samples for blood routine testing and C-reactive protein testing

OTHER

Nasal swab/Nasopharyngeal swab/Blood draw

Visit 1/2/3：Collect nasal or nasopharyngeal swab samples, 15ml anticoagulant samples and 3ml procoagulant samples, as well as 2ml blood samples for blood routine testing and C-reactive protein testing

OTHER

Nasal swab/Nasopharyngeal swab/Blood draw

Visit 1/2/3：Collect nasal or nasopharyngeal swab samples, 15ml anticoagulant samples and 3ml procoagulant samples, as well as 2ml blood samples for blood routine testing and C-reactive protein testing

Trial Locations (2)

430000

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
collaborator

Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China

OTHER

lead

Zhongnan Hospital

OTHER